Fabtech Technologies Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹552 Cr
- P/E
- 11.34
- ROE
- 12.02%
- PEG
- 0.64
- Price to sales
- 1.32
- Debt to equity
- 0.17
- 52W high / low
- ₹252 / ₹120
- Sales growth (5Y)
- 27.69%
- EBITDA margin
- 10.85%
- Net profit margin
- 8.67%
- Promoter holding
- 69.03%
- Sales (last year)
- ₹418 Cr
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]
Guidance scorecard · Q2 FY27 call
What Fabtech Technologies Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
20–40%- Fabtech Technologies aims for 20-25% year-on-year organic growth.
- Target to achieve ₹1000 crore+ top-line by 2030, considered a conservative estimate.
- Q2 is expected to be steady, with stronger H2 performance typically seen in the EPC design and build industry.
- Active inquiries exceed ₹9300 crore with hot leads over ₹3800 crore, providing two-year sales visibility.
- Growth driven by deeper localization, pipeline conversion with disciplined order selection focusing on quality, and integration of acquisitions to boost local execution.
- Expansion into GCC, Eastern and Southern Africa markets, notably through Fabtech Life Care in Saudi Arabia.
2 more points from Fabtech Technologies Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Up 0–2%See what Fabtech Technologies Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Capital allocation focuses on execution, with working capital released only when order book growth and project requirements align.
- Acquisitions are strategically fit-driven, with capital deployment following due diligence and integration suitability.
- Investments post-IPO have been made in leadership and operational excellence.
- Technology investments include digital tools, 3D modeling, and AI integration to improve project delivery timelines.
FundraisingQ1 FY27 call
See what Fabtech Technologies Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Rising- The current open order book is reported to be over ₹900 crores (approximately ₹920+ crores considering exchange rate fluctuations).
- During Q1 FY27, new order inflows of ₹96.5 crores were added, while around ₹75 crores of orders were delivered.
- Order book revenue recognition does not occur evenly across quarters; Q1 is typically the lightest in revenue due to milestone-based recognition.
- Active inquiries exceed ₹9,300 crores in the total addressable funnel.
- Hot leads, representing advanced commercial or technical opportunities with a path to conversion, are valued over ₹3,800 crores.
2 more points from Fabtech Technologies Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | Fabtech Tech.This stock | 20–40% | Up 0–2% | ₹580 Cr | 11.9 |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Fabtech Technologies Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Fabtech Technologies Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Fabtech Technologies Ltd
Shareholding breakup across reporting periods.
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Promoters + | 68.94% | 68.94% | 68.94% | 69.03% |
| FIIs + | 0.03% | 0.08% | 0.02% | 0.02% |
| DIIs + | 1.99% | 2.15% | 2.45% | 2.45% |
| Public + | 29.04% | 28.83% | 28.57% | 28.49% |
| No. of Shareholders | 31,755 | 28,620 | 29,408 | 28,336 |
Financials of Fabtech Technologies Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 59 | 104 | 135 | 68 | 121 | 63 | 159 | 75 | 92 |
| Expenses + | 54 | 81 | 116 | 74 | 91 | 74 | 136 | 71 | 82 |
| Operating Profit | 5 | 23 | 18 | -6 | 30 | -12 | 22 | 4 | 10 |
| OPM % | 8% | 22% | 14% | -9% | 25% | -18% | 14% | 6% | 11% |
| Other Income + | 2 | 2 | 3 | 3 | 3 | 7 | 10 | 3 | 14 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 6 | 24 | 20 | -6 | 31 | -7 | 30 | 5 | 22 |
| Tax % | 15% | 13% | 24% | -1% | 10% | -15% | 26% | 20% | 31% |
| Net Profit + | 5 | 20 | 15 | -6 | 28 | -6 | 22 | 4 | 15 |
| EPS in Rs | 1.58 | 6.32 | 4.66 | -1.89 | 8.68 | -1.28 | 4.96 | 0.95 | 3.38 |
Financials of Fabtech Technologies Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 388 |
| Expenses + | 119 | 110 | 225 | 169 | 191 | 288 | 374 | 363 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 37 | 25 |
| OPM % | 11% | 9% | 12% | 13% | 15% | 12% | 9% | 6% |
| Other Income + | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 34 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 6 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 50 |
| Tax % | 27% | 29% | 25% | 22% | 24% | 23% | 21% | |
| Net Profit + | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 36 |
| EPS in Rs | 1,239.00 | 804.00 | 7.67 | 7.10 | 8.40 | 14.34 | 8.63 | 8.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Fabtech Technologies Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 3 | 3 | 3 | 32 | 44 | 44 |
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 | 395 |
| Borrowings + | 1 | 9 | 21 | 35 | 13 | 84 | 70 | 57 |
| Other Liabilities + | 84 | 70 | 83 | 89 | 125 | 170 | 209 | 189 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 699 | 686 |
| Fixed Assets + | 2 | 2 | 5 | 4 | 22 | 94 | 78 | 75 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 29 | 29 |
| Other Assets + | 109 | 116 | 150 | 190 | 226 | 318 | 591 | 582 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 699 | 686 |
Financials of Fabtech Technologies Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity + | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity + | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | -0 | 18 | -20 | 78 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | -4 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 417% | -65% | 4% | -15% | 196% | -68% | 34% |
Financials of Fabtech Technologies Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 135 | 120 | 187 | 156 | 168 | 215 |
| Inventory Days | 22 | 39 | 17 | 69 | 88 | 119 | 32 |
| Days Payable | 82 | 150 | 136 | 215 | 195 | 198 | 215 |
| Cash Conversion Cycle | 51 | 25 | 1 | 41 | 49 | 89 | 32 |
| Working Capital Days | -19 | 15 | 30 | 65 | 63 | 53 | 79 |
| ROCE % | 26% | 48% | 31% | 28% | 22% | 14% |
Guidance history
How Fabtech Technologies Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 20–40% | Up 0–2% | Planned | — | Rising |
| Q4 FY26 call → | 20–40% | Flat | Planned | None planned | Rising |
| Q3 FY26 call → | 20–40% | Flat | Planned | — | Rising |
| Q2 FY26 call → | 20–40% | Flat | None planned | — | Rising |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
7 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −46.9% | 7% |
| Last 6 months | −26.5% | 12% |
| Last 3 months | −17.1% | 28% |
The price is 51.5% below its all-time high of ₹255.41 (28 Oct 2025). Stocks more than 20% below their peak have their score halved, so 13 became 7.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Fabtech Technologies Ltd: 0.4 × 7 + 0.4 × 12 + 0.2 × 28 = 13, halved to 7 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Fabtech Technologies Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Indegene Ltd (Q2 FY27)
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo